This paper is only available as a PDF. To read, Please Download here.
Reductions in circulating estradiol concentrations could be implicated in the pathogenesis of steroid-induced osteoporosis (SIOP) in men. We assessed serum estradiol and adrenal androgens (dehydroepiandrosterone sulfate [DHEAS] and androstenedione) in 77 men (group A: idiopathic osteoporosis [IOP], n = 38, aged [mean [plusmn] SD] 57.7 [plusmn] 12.1 years; group B: SIOP, n = 39, aged 55.3 [plusmn] 13.1 years). We also studied the relationship between bone mineral density (BMD) and serum estradiol in the group of men with SIOP. In group B, we observed a higher prevalence of low serum testosterone concentrations ([lt ]9.0 nmol/L) (P = .0052), which was significantly correlated with steroid dosage (r = [minus ]0.42, P = .0089) and estradiol concentrations (r = 0.42, P = .012). There was a significant positive association between BMD at the lumbar spine and serum estradiol (P = .004) in the men with SIOP (group B). A high proportion of subjects had low serum estradiol concentrations ([lt ]48 pmol/L) in both groups (group A: 44.7 %, group B: 36 %). Serum adrenal androgens concentrations were also significantly suppressed in group B (serum androstenedione[mdash ]group A: 4.99 [plusmn] 1.8; Group B: 2.1 [plusmn] 1.6 nmol/L; P = .0001). Serum DHEAS was undetectable in 59% of patients in group B versus 6% in group A (P = .001). Reductions in androstenedione also correlated with steroid dosage (r = [minus ]0.35, P = .01). In conclusion, the data show that adrenal androgens synthesis is markedly suppressed in men with SIOP. The clinical relevance of this finding remains to be determined. This study also shows a positive association between serum estradiol and BMD and a high prevalence of low serum estradiol in men with SIOP. Low serum estradiol may contribute to bone loss in men with SIOP.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Metabolism - Clinical and Experimental
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2002 Published by Elsevier Inc. All rights reserved.